Navigation Links
Anpath Group, Inc. Announces Selection of its Cleaner by the Toronto Transit System
Date:6/4/2009

MOORESVILLE, N.C., June 4 /PRNewswire-FirstCall/ -- Anpath Group, Inc. (OTC Bulletin Board: ANPG), reported today that its wholly-owned subsidiary, EnviroSystems, Inc. (ESI) announced the selection of its cleaner deodorizer, SurfaceTru(TM) for use by the Toronto Transit Commission, Toronto, Ontario Canada.

SurfaceTru(TM) is a powerful, multi-purpose cleaner deodorizer that is safe for use on a variety of surfaces. In addition to being gentle to surfaces, SurfaceTru(TM) is safe for the user and friendly to the environment. It does not require gloves, protective clothing, special ventilation or special handling requirements and is non-flammable. According to ESI, SurfaceTru(TM) is ideally suited for use in a transit system environment. As a result of its cleaning characteristics combined with its favorable materials compatibility and environmental profile, SurfaceTru(TM) is a natural choice for heavy traffic areas.

The Toronto Transit Commission (TTC) is a public transport authority that operates buses, streetcars, subways, and rapid transit lines in Toronto, Ontario Canada. The TTC operates 149 surface transit routes, of which 148 routes make 243 connections with a subway or rapid transit station during weekday rush hours. In 2007, the TTC carried 1.5 million passengers per day, and there were 459,769,000 passenger trips in total. The TTC employed 11,235 personnel in 2007. The TTC operates the third most heavily-used urban mass transit system in North America (after the New York City Transit Authority, and the Mexico City Metro).

About Anpath Group, Incorporated:

Anpath Group, Inc. (Anpath), through its wholly-owned subsidiary EnviroSystems, Inc., produces cleaning and disinfecting products that it believes will help prevent the spread of infectious microorganisms while minimizing the harmful effects to people, equipment or the environment. Visit www.anpathgroup.com for more information.

EnviroSystems, Inc. is focused on safe infection prevention technologies that the company believes will position the company in the forefront of the industry at a time when there is rapidly growing awareness of the critical need to prevent biological risks - both natural and man-made. Visit www.envirosi.com for more information.

Forward Looking Statements:

This release contains forward-looking statements, which reflect expectation or belief by Anpath Group, Inc. concerning future events that involve risks and uncertainties. Anpath Group can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Anpath Group expectations, including, but not limited to EPA and state registration of the Company's products, the Company's ability to carry out its business plan, successful development and commercial acceptance of its products, ability to fund development of its technology, the risk that products may not result from development activities, protection of its intellectual property, need for regulatory approvals, and other factors discussed in periodic Anpath Group, Inc. filings with the Securities and Exchange Commission. Forward-looking statements are qualified in their entirety by the above cautionary statement. Anpath Group assumes no duty to update its outlook or other forward-looking statements as of any future date.


'/>"/>
SOURCE Anpath Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Anpath Group, Inc. Distributor Introduces Products at the Japanese Society of Intensive Care Medicine Annual Meeting
2. Anpath Group, Inc. Increases Market Share in Korea
3. Anpath Group, Inc. Announces Intent To Seek Shareholder Approval for a Reverse Split of Its Common Stock
4. Anpath Group, Inc. Expands International Distribution With Minntech Corporation
5. Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors
6. Anpath Group, Inc. Announces Advancements with Animal Care Line
7. NYSE Amex LLC Accepts Plan of Compliance of The Quantum Group, Inc.
8. Lightspeed Research - The Foresight Group, Announced Today that Holly Bossert has Joined the Company as a Senior Account Manager for the East Coast
9. WeissComm Group Acquires Common Sense Media Group, Appoints Founder Bob Pearson Chief Technology and Media Officer to Help Clients Evaluate and Optimize Social Media
10. Hanger Orthopedic Group, Inc. Announces Two Acquisitions Totaling $5.3 Million of Annual Net Revenue
11. NSD Bio Group, LLC Selected By U.S. - China Economic & Security Review Commission for Analysis of Chinas Pharma Supply Chain on U.S. Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... reviews on the independent review site Consumer Affairs have ... hearing aids, ranking it higher than Miracle Ear ™, Beltone™, ... ... Aids ... that provides high performance, state-of-the-art, German-engineered hearing aids directly to consumers ...
Breaking Medicine Technology: